Amgen, Takeda Acquisition Targets Involve Limited Exposure To Medicare – And Price Controls

 
• By Cathy Kelly
  
M&A perspectives
Recent M&A deals suggest industry is appreciating the impact of IRA, the new Medicare pricing law. • Source: Shutterstock

More from Market Access

More from Pink Sheet